Quantifying prescribed high dose opioids in the community and risk of overdose
Abstract Background Opioid prescribing for a range of health issues is increasing globally. The risk of fatal and non-fatal overdose is increased among people prescribed strong opioids: in high doses in the context of polypharmacy (the use of multiple medications at the same time), especially with o...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-06-01
|
Series: | BMC Public Health |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12889-021-11162-4 |
id |
doaj-f13b5637cc4342f395169fa6e1b0f8ba |
---|---|
record_format |
Article |
spelling |
doaj-f13b5637cc4342f395169fa6e1b0f8ba2021-06-27T11:04:07ZengBMCBMC Public Health1471-24582021-06-0121111110.1186/s12889-021-11162-4Quantifying prescribed high dose opioids in the community and risk of overdoseJoe Schofield0Deborah Steven1Rebecca Foster2Catriona Matheson3Alexander Baldacchino4Andrew McAuley5Tessa Parkes6Salvation Army Centre for Addiction Services and Research, Faculty of Social Sciences, Colin Bell Building, University of StirlingFife Pain Management Service, NHS Fife, Lynebank HospitalSalvation Army Centre for Addiction Services and Research, Faculty of Social Sciences, Colin Bell Building, University of StirlingSalvation Army Centre for Addiction Services and Research, Faculty of Social Sciences, Colin Bell Building, University of StirlingPopulation and Behavioural Science Division, School of Medicine, University of St AndrewsSchool of Health and Life Sciences, Glasgow Caledonian UniversitySalvation Army Centre for Addiction Services and Research, Faculty of Social Sciences, Colin Bell Building, University of StirlingAbstract Background Opioid prescribing for a range of health issues is increasing globally. The risk of fatal and non-fatal overdose is increased among people prescribed strong opioids: in high doses in the context of polypharmacy (the use of multiple medications at the same time), especially with other sedatives; and among people with multiple morbidities including cardiorespiratory, hepatic and renal conditions. This study described and quantified the prescribing of strong opioids, comorbidities and other overdose risk factors among those prescribed strong opioids, and factors associated with high/very high opioid dosage in a regional health authority in Scotland as part of a wider service improvement exercise. Methods Participating practices ran searches to identify patients prescribed strong opioids and their characteristics, polypharmacy, and other overdose risk factors. Data were anonymised before being analysed at practice and patient-level. Morphine Equivalent Doses were calculated for patients based on drug/dose information and classed as Low/Medium/High/Very High. Descriptive statistics were generated on the strong opioid patient population and overdose risk factors. The relationship between the prescribing of strong opioids and practice/patient-level factors was investigated using linear and logistic regression models. Results Eighty-five percent (46/54) of GP practices participated. 12.4% (42,382/341,240) of individuals in participating practices were prescribed opioids and, of these, one third (14,079/42,382) were prescribed strong opioids. The most common comorbidities and overdose risk factors among strong opioid recipients were pain (67.2%), cardiovascular disease (43.2%), and mental health problems (39.3%). There was a positive significant relationship between level of social deprivation among practice caseload and level of strong opioid prescribing (p < 0.001). People prescribed strong opioids tended to be older (mean 59.7 years) and female (8638, 61.4%) and, among a subset of patients, age, gender and opioid drug class were significantly associated with prescribing of High/Very High doses. Conclusions Our findings have identified a large population at potential risk of prescription opioid overdose. There is a need to explore pragmatic models of tailored interventions which may reduce the risk of overdose within this group and clinical practice may need to be tightened to minimise overdose risk for individuals prescribed high dose opioids.https://doi.org/10.1186/s12889-021-11162-4Prescription opioidsOverdoseAnalgesicsComorbiditiesGeneral practicePolypharmacy |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Joe Schofield Deborah Steven Rebecca Foster Catriona Matheson Alexander Baldacchino Andrew McAuley Tessa Parkes |
spellingShingle |
Joe Schofield Deborah Steven Rebecca Foster Catriona Matheson Alexander Baldacchino Andrew McAuley Tessa Parkes Quantifying prescribed high dose opioids in the community and risk of overdose BMC Public Health Prescription opioids Overdose Analgesics Comorbidities General practice Polypharmacy |
author_facet |
Joe Schofield Deborah Steven Rebecca Foster Catriona Matheson Alexander Baldacchino Andrew McAuley Tessa Parkes |
author_sort |
Joe Schofield |
title |
Quantifying prescribed high dose opioids in the community and risk of overdose |
title_short |
Quantifying prescribed high dose opioids in the community and risk of overdose |
title_full |
Quantifying prescribed high dose opioids in the community and risk of overdose |
title_fullStr |
Quantifying prescribed high dose opioids in the community and risk of overdose |
title_full_unstemmed |
Quantifying prescribed high dose opioids in the community and risk of overdose |
title_sort |
quantifying prescribed high dose opioids in the community and risk of overdose |
publisher |
BMC |
series |
BMC Public Health |
issn |
1471-2458 |
publishDate |
2021-06-01 |
description |
Abstract Background Opioid prescribing for a range of health issues is increasing globally. The risk of fatal and non-fatal overdose is increased among people prescribed strong opioids: in high doses in the context of polypharmacy (the use of multiple medications at the same time), especially with other sedatives; and among people with multiple morbidities including cardiorespiratory, hepatic and renal conditions. This study described and quantified the prescribing of strong opioids, comorbidities and other overdose risk factors among those prescribed strong opioids, and factors associated with high/very high opioid dosage in a regional health authority in Scotland as part of a wider service improvement exercise. Methods Participating practices ran searches to identify patients prescribed strong opioids and their characteristics, polypharmacy, and other overdose risk factors. Data were anonymised before being analysed at practice and patient-level. Morphine Equivalent Doses were calculated for patients based on drug/dose information and classed as Low/Medium/High/Very High. Descriptive statistics were generated on the strong opioid patient population and overdose risk factors. The relationship between the prescribing of strong opioids and practice/patient-level factors was investigated using linear and logistic regression models. Results Eighty-five percent (46/54) of GP practices participated. 12.4% (42,382/341,240) of individuals in participating practices were prescribed opioids and, of these, one third (14,079/42,382) were prescribed strong opioids. The most common comorbidities and overdose risk factors among strong opioid recipients were pain (67.2%), cardiovascular disease (43.2%), and mental health problems (39.3%). There was a positive significant relationship between level of social deprivation among practice caseload and level of strong opioid prescribing (p < 0.001). People prescribed strong opioids tended to be older (mean 59.7 years) and female (8638, 61.4%) and, among a subset of patients, age, gender and opioid drug class were significantly associated with prescribing of High/Very High doses. Conclusions Our findings have identified a large population at potential risk of prescription opioid overdose. There is a need to explore pragmatic models of tailored interventions which may reduce the risk of overdose within this group and clinical practice may need to be tightened to minimise overdose risk for individuals prescribed high dose opioids. |
topic |
Prescription opioids Overdose Analgesics Comorbidities General practice Polypharmacy |
url |
https://doi.org/10.1186/s12889-021-11162-4 |
work_keys_str_mv |
AT joeschofield quantifyingprescribedhighdoseopioidsinthecommunityandriskofoverdose AT deborahsteven quantifyingprescribedhighdoseopioidsinthecommunityandriskofoverdose AT rebeccafoster quantifyingprescribedhighdoseopioidsinthecommunityandriskofoverdose AT catrionamatheson quantifyingprescribedhighdoseopioidsinthecommunityandriskofoverdose AT alexanderbaldacchino quantifyingprescribedhighdoseopioidsinthecommunityandriskofoverdose AT andrewmcauley quantifyingprescribedhighdoseopioidsinthecommunityandriskofoverdose AT tessaparkes quantifyingprescribedhighdoseopioidsinthecommunityandriskofoverdose |
_version_ |
1721358332566962176 |